Hepatopulmonary Syndrome and Portopulmonary Hypertension

References

• . Rodriguez-Roisin R, Agust AG, Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax. 1992;47(11):897–902
   PubMedGoogle Scholar
• . Rodriguez-Roisin R, Krowka MJ, Hervé P, Fallon MB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24(5):861–880
   PubMed Web of Science ®Google Scholar
• . Schenk P, Fuhrmann V, Madi C, . Hepatopulmonary syndrome: prevalence and predictive value of various cutoffs for arterial oxygenation and their clinical consequences. Gut. 2002;51(6):853–859
   PubMed Web of Science ®Google Scholar
• . Fallon MB, Krowka MJ, Brown, . Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008;135(4):1168–1175
   PubMed Web of Science ®Google Scholar
• . Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary Syndrome: impact of liver transplantation. Hepatology. 2005;41(5):1122–1129
   PubMedGoogle Scholar
• . Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome—a liver-induced lung vascular disorder. New Engl J Med. 2008;358(22):2378–2387
   PubMed Web of Science ®Google Scholar
• . Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis. 1987;135(5):1085–1092
   PubMedGoogle Scholar
• . Stanley NN, Williams AJ, Dewar CA, Blendis LM, Reid L. Hypoxia and hydrothoraces in a case of liver cirrhosis: correlation of physiological, radiographic, scintigraphic, and pathological findings. Thorax. 1977;32(4):457–471
   PubMedGoogle Scholar
• . Genovesi MG, Tierney DF, Taplin GV, Eisenberg H. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Limitation of conventional techniques. Am Rev Respir Dis. 1976;114(1):59–65
   PubMedGoogle Scholar
• . Cremona G, Higenbottam TW, Mayoral V, . Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J. 1995;8(11):1883–1885
   PubMedGoogle Scholar
• . Rolla, G, Brussino L, Colagrande P, . Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med. 1998;129(5):375–378
   PubMedGoogle Scholar
• . Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;363(9419):1461–1468
   PubMedGoogle Scholar
• . Schraufnagel DE, Malik R, Goel V, Ohara N, Chang SW. Lung capillary changes in hepatic cirrhosis in rats. Am J Physiol. 1997;272(1 pt 1):139–147
   Google Scholar
• . Schenk P, Madl C, Rezaie-Majd S, Lehr S, Müller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med. 2000;133(9):701–706
   PubMed Web of Science ®Google Scholar
• . Gomez FP, Barberà JA, Roca J, Burgos F, Gistau C, Rodríguez-Roisin R. Effects of nebulized N(G)-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006;43(5):1084–1091
   PubMed Web of Science ®Google Scholar
• . Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology. 1997;113(2):606–614
   PubMedGoogle Scholar
• . Tang L, Luo B, Patel RP, Ling Y, Zhang J, Fallon MB. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol. 2007;292(6):L1467–L1472
   Google Scholar
• . Zhang J, Ling Y, Luo B, . Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology. 2003;125(5):1441–1451
   PubMed Web of Science ®Google Scholar
• . Zhang J, Luo B, Tang L, . Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology. 2009;136(3):1070–1080
   PubMedGoogle Scholar
• . Gómez FP, Martínez-Pallí G, Barberà JA, Roca J, Navasa M, Rodríguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology. 2004;40(3):660–666
   PubMedGoogle Scholar
• . Martinez G, Barberà JA, Navasa M, Roca J, Visa J, Rodriguez-Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol. 1999;30(5):882–889
   PubMedGoogle Scholar
• . Krowka MJ. Hepatopulmonary syndromes. Gut. 2000;46(1):1–4
   PubMedGoogle Scholar
• . Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology. 1995;109(4):1283–1288
   PubMedGoogle Scholar
• . Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest. 1993;104(2):515–521
   PubMedGoogle Scholar
• . Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med. 1996;17(1):35–48
   PubMedGoogle Scholar
• . Lima BL, França AV, Pazin-Filho A, . Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc. 2004;79(1):42–48
   PubMedGoogle Scholar
• . Hourani JM, Bellamy PE, Tashkin DP, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med. 1991;90(6):693–700
   PubMedGoogle Scholar
• . Lasch HM, Fried MW, Zacks SL . Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl. 2001;7(2):147–149
   PubMedGoogle Scholar
• . Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol. 1998;93(3):455–458
   PubMedGoogle Scholar
• . Corley DA, Scharschmidt B, Bass N, Somberg K, Gold W. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology. 1997;113(2):728–730
   PubMedGoogle Scholar
• . Taillé C, Cadranel J, Bellocq A, . Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation. 2003;75(9): 1482–1489; discussion 1446–1447
   PubMedGoogle Scholar
• . Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med. 2005;26(4):587–597, vi
   PubMedGoogle Scholar
• . Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology. 2003;37(1):192–197
   PubMedGoogle Scholar
• . Krowka MJ, Mandell MS, Ramsay MA, . Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004;10(2):174–182
   PubMedGoogle Scholar
• . Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125(4):1042–1052
   PubMed Web of Science ®Google Scholar
• . Krowka MJ, Porayko MK, Plevak DJ, . Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc. 1997;72(1):44–53
   PubMedGoogle Scholar
• . Schiffer E, Majno P, Mentha G, . Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant. 2006;6(6):1430–1437
   PubMedGoogle Scholar
• . Lange PA, Stoller JK. The hepatopulmonary syndrome. Effect of liver transplantation. Clin Chest Med. 1996;17(1):115–123
   PubMedGoogle Scholar
• . Schwarzenberg SJ, Freese DK, Regelmann WE, . Resolution of severe intrapulmonary shunting after liver transplantation. Chest. 1993;103(4):1271–1273
   PubMedGoogle Scholar
• . Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J. 2005;25(5):783–788
   PubMed Web of Science ®Google Scholar
• . Simonneau G, Robbins IM, Beghetti M, . Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54( 1 suppl):s43–s54
   PubMed Web of Science ®Google Scholar
• . Simonneau G, Galiè N, Rubin LJ, . Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 suppl S):5S–12S
   Web of Science ®Google Scholar
• . McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis. 1983;127(4):437–441
   PubMedGoogle Scholar
• . Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100(2):520–528
   PubMedGoogle Scholar
• . Yang YY, Lin HC, Lee WC, . Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations. J Gastroenterol. 2001;36(3):181–186
   PubMedGoogle Scholar
• . Castro M, Krowka MJ, Schroeder DR, . Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996;71(6):543–551
   PubMedGoogle Scholar
• . Torregrosa M, Genesca J, Gonzalez A, . Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Transplantation. 2001;71(4):572–574
   PubMedGoogle Scholar
• . Colle IO, Moreau R, Godinho E, . Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37(2):401–409
   PubMedGoogle Scholar
• . Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006;44(6):1502–1510
   PubMedGoogle Scholar
• . Herve P, Lebrec D, Brenot F, . Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998;11(5):1153–1166
   PubMedGoogle Scholar
• . Rich S, Dantzker DR, Ayres SM, . Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107(2):216–223
   PubMed Web of Science ®Google Scholar
• . Robalino BD, Moodie DS. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol. 1991;17(2):492–498
   PubMedGoogle Scholar
• . Kawut SM, Taichman DB, Ahya VN, . Hemodynamics and survival of patients with portopulmonary hypertension. Liver Transpl. 2005;11(9):1107–1111
   PubMedGoogle Scholar
• . Krowka MJ, Miller DP, Barst RJ, . Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012;141(4):906–915
   PubMed Web of Science ®Google Scholar
• . Golbin JM, Krowka MJ. Portopulmonary hypertension. Clin Chest Med. 2007;28(1):203–218, ix
   PubMedGoogle Scholar
• . Passarella M, Fallon MB, Kawut SM. Portopulmonary hypertension. Clin Liver Dis. 2006;10(3):653–663, x
   PubMedGoogle Scholar
• . Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med. 1996;17(1):17–33
   PubMedGoogle Scholar
• . Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991;114(6):464–469
   PubMed Web of Science ®Google Scholar
• . Benjaminov FS, Prentice M, Sniderman KW, Siu S, Liu P, Wong F. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut. 2003;52(9):1355–1362
   PubMedGoogle Scholar
• . Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351(16):1655–1665
   PubMed Web of Science ®Google Scholar
• . Budhiraja R. Portopulmonary hypertension: a tale of two circulations. Chest. 2003;123(2):562–576
   PubMedGoogle Scholar
• . Murray KF, Carithers RL Jr; AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005;41(6):1407–1432
   PubMed Web of Science ®Google Scholar
• . Swanson KL, Krowka MJ. Portopulmonary hypertension. In: Mandel J, Taichman D, eds. Pulmonary Vascular Disease. Philadelphia, PA: Saunders. 2006
   Google Scholar
• . Kim WR, Krowka MJ, Plevak DJ, . Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000;6(4):453–458
   PubMedGoogle Scholar
• . Cotton CL, Gandhi S, Vaitkus PT, . Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl. 2002;8(11):1051–1054
   PubMedGoogle Scholar
• . Krowka MJ. Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis. 2006;26(3):265–272
   PubMedGoogle Scholar
• . Hoeper MM Rubin LJ. Update in pulmonary hypertension 2005. Am J Respir Crit Care Med. 2006;173(5):499–505
   PubMedGoogle Scholar
• . Rich S, Seidlitz M, Dodin E, . The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest. 1998;114(3):787–792
   PubMed Web of Science ®Google Scholar
• . Provencher S, Herve P, Jais X, . Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology. 2006;130(1):120–126
   PubMedGoogle Scholar
• . Ota K, Shijo H, Kokawa H, . Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis. J Gastroenterol Hepatol. 1995;10(2):198–204
   PubMedGoogle Scholar
• . Plotkin JS, Kuo PC, Rubin LJ, . Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation. 1998;65(4):457–459
   PubMedGoogle Scholar
• . Kato H, Katori T, Nakamura Y, Kawarasaki H. Moderate-term effect of epoprostenol on severe portopulmonary hypertension. Pediatr Cardiol. 2003;24(1):50–53
   PubMedGoogle Scholar
• . Ashfaq M, Chinnakotla S, Rogers L, . The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant. 2007;7(5):1258–1264
   PubMedGoogle Scholar
• . Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008;8(11):2445–2453
   PubMedGoogle Scholar
• . Findlay JY, Plevak DJ, Krowka MJ, Sack EM, Porayko MK. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg. 1999;5(5):362–365
   PubMedGoogle Scholar
• . Hoeper MM, Seyfarth HJ, Hoeffken G, . Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J. 2007;30(6):1096–1102
   PubMedGoogle Scholar
• . Rubin LJ Roux S. Bosentan: a dual endothelin receptor antagonist. Expert Opin Investig Drugs. 2002;11(7):991–1002
   PubMedGoogle Scholar
• . Fattinger K, Funk C, Pantze M, . The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther. 2001;69(4):223–231
   PubMed Web of Science ®Google Scholar
• . Cartin-Ceba R, Swanson K, Iyer V, Wiesner RH, Krowka MJ. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest. 2011;139(1):109–114
   PubMed Web of Science ®Google Scholar
• . Watanabe H, Ohashi K, Takeuchi K, . Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther. 2002;71(5):398–402
   PubMed Web of Science ®Google Scholar
• . Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation. 2002;105(20):2398–2403
   PubMedGoogle Scholar
• . Makisalo H, Koivusalo A, Vakkuri A, Hockerstedt K. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl. 2004;10(7):945–950
   PubMedGoogle Scholar
• . Paulsen AW, Whitten CW, Ramsay MA, Klintmalm GB. Considerations for anesthetic management during veno-venous bypass in adult hepatic transplantation. Anesth Analg. 1989;68(4):489–496
   PubMedGoogle Scholar
• . Acosta F, Sansano T, Palenciano CG, . Portopulmonary hypertension and liver transplantation: hemodynamic consequences at reperfusion. Transplant Proc. 2005;37(9):3865–3866
   PubMedGoogle Scholar
• . Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000;6(4):443–450
   PubMed Web of Science ®Google Scholar
• . Ramsay MA, Simpson BR, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg. 1997;3(5):494–500
   PubMedGoogle Scholar